Intrabodies for Huntington's and Parkinson's disease therapeutics

Add to your list(s) Download to your calendar using vCal

• Anne Messer, Ph.D. Professor of Biomedical Sciences, University at Albany Senior Scientist, Neural Stem Cell Institute Albany/ Rensselaer, NY, USA
• Wednesday 13 November 2013, 14:00-15:00
• University of Cambridge Department of Chemistry Pfizer Lecture Theatre.

If you have a question about this talk, please contact ejjd2.

Accumulation of misfolded proteins characterizes several important neurodegenerative diseases, including Huntington’s and Parkinson’s. The specificity and engineering potential of antibody fragments offers multifunctional approaches to modify the toxic effects of such proteins. By targeting the proteins intracellularly, intervention can occur at the earliest stage in a pathogenic cascade. Huntington’s offers particularly robust models and the can serve as a paradigm for related disorders.

This talk is part of the Cambridge Neuroscience Seminars series.

This talk is included in these lists:

• Biology
• Cambridge Neuroscience Seminars
• Cambridge talks
• Chris Davis' list
• Featured lists
• Life Science
• Life Sciences
• Neuroscience
• Neuroscience Seminars
• Neuroscience Seminars
• Stem Cells & Regenerative Medicine
• University of Cambridge Department of Chemistry Pfizer Lecture Theatre
• dh539
• kt532's list

Note that ex-directory lists are not shown.